Clinical Conclusions to Elipulse Studies

 

Conclusion: Elipulse Safety and Efficacy

 

The discussion of clinical literature research, clinical research, quality analysis, pharmacological research, safety research, plant composition mechanism, etc. in this review shows that: Elipulse is effective in the adjuvant therapy of the chronic coronary heart disease（CAD）, angina pectoris, chronic heart failure （CHF）, and is safe without toxic side effects. The quality of plant materials for medicine is reliable, quality standard is complete and manufacturing technique is standard. It has approved by Canadian Natural Product License and is sold widespread in the market, providing a kind of healthy food used for auxiliary treatment for patients suffering from such kind of diseases.